0001582636-26-000002.txt : 20260910 0001582636-26-000002.hdr.sgml : 20260910 20260910163430 ACCESSION NUMBER: 0001582636-26-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260910 DATE AS OF CHANGE: 20260910 EFFECTIVENESS DATE: 20260910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALZHEON, INC. CENTRAL INDEX KEY: 0001582636 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 463074149 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-597067 FILM NUMBER: 261371533 BUSINESS ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 BUSINESS PHONE: 508-861-7709 MAIL ADDRESS: STREET 1: 111 SPEEN STREET STREET 2: SUITE 306 CITY: FRAMINGHAM STATE: MA ZIP: 01701 D 1 primary_doc.xml X0708 D LIVE 0001582636 ALZHEON, INC. 111 SPEEN STREET SUITE 306 FRAMINGHAM MA MASSACHUSETTS 01701 508-861-7709 DELAWARE None None Corporation true Martin Tolar, M.D., Ph.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Director President and Chief Executive Officer Christopher Noel Dunn 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Neil W. Flanzraich 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Jordan Heller 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Diane K. Jorkasky, M.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Gino Santini 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Muneer Satter 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Director Kenneth Mace 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Treasurer and Chief Financial Officer Susan Abushakra, M.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Medical Officer John Hey, Ph.D. 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Scientific Officer Aidan Power, MRCPsych 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Development Officer Adem Albayrak 111 Speen Street Suite 306 Framingham MA MASSACHUSETTS 01701 Executive Officer Chief Data Officer Biotechnology Decline to Disclose 06b false 2026-08-26 true true false 0 499999999 78797184 421202815 false 3 0 0 0 false ALZHEON, INC. /s/ Martin Tolar, M.D., Ph.D. Martin Tolar, M.D., Ph.D. President and Chief Executive Officer 2026-09-10